Alibaba（09988）

市场: 港股日期: 2026-07-06评级: Investment Recommendation: Sell. Target Price: 84.75 HKD. Basis: Fundamentals show profit decline of 20.38% and stagnant revenue; technicals show bearish arrangement and shrinking volume on rebounds; low P/B but low ROE constitutes a value trap; lack of reversal catalysts; downside risk is clear; should sell with the trend.风险: Moderate置信度: 0.7

market_report

# **Alibaba (09988) Technical Analysis Report** **Analysis Date: July 07, 2026 (based on latest available data July 03, 2026)** --- ## 1. Basic Stock Information - **Company Name**: Alibaba - **Stock Code**: 09988 - **Market**: Hong Kong Stock Exchange - **Current Price**: HK$ 94.10 - **Change**: -0.42% (vs previous closing price HK$ 94.50) - **Trading Volume**: 67,295,654 shares --- ## 2. Technical Indicator Analysis ### 1. Moving Average (MA) Analysis The current price HK$ 94.10 is significantly below all major moving averages, showing a typical bearish alignment: - **MA5 (92.79)**: The stock price is slightly above the 5-day MA, showing initial signs of stabilization in the short term. - **MA10 (96.51)**: The price is below the 10-day MA, and the short-term rebound has not yet broken through this resistance. - **MA20 (104.85)**: The price is far below the 20-day MA, and the medium-term trend remains weak. - **MA60 (120.76)**: The price is substantially below the 60-day MA, indicating a clear bearish pattern in the long-term trend. The order of moving averages is MA60 > MA20 > MA10 > MA5, which is a standard bearish alignment, indicating that overall market downward pressure remains significant. ### 2. MACD Indicator Analysis - **DIF**: -8.13 - **DEA**: -7.54 - **MACD Histogram**: -1.18 All MACD values are negative, with DIF below DEA and the histogram remaining negative, indicating that overall momentum is still bearish. However, the negative values have narrowed slightly recently, suggesting that downward momentum may be weakening, but no clear golden cross reversal signal has appeared yet, requiring continued observation. ### 3. Relative Strength Index (RSI) - **RSI(14)**: 29.69 The RSI value is below 30, entering the 'oversold' zone. This usually means that the stock price may have fallen too much in the short term, and market sentiment has approached extreme pessimism, opening the possibility of a technical rebound. However, it should be noted that during a strong downtrend, the RSI may linger in oversold territory, and the timing of a rebound needs to be confirmed by other conditions. ### 4. Bollinger Bands (BOLL) Analysis - **Upper Band**: HK$ 124.95 - **Middle Band**: HK$ 104.85 - **Lower Band**: HK$ 84.75 The current price HK$ 94.10 is between the middle and lower bands, clearly biased downward, indicating the price is in a weak zone. The Bollinger Bands are relatively wide, suggesting recent high volatility. The stock price is still about 9.0% away from the lower band (approximately HK$ 84.75), which will be an important technical support reference. --- ## 3. Price Trend Analysis ### 1. Short-Term Trend Looking at the last 10 trading days, the stock experienced a sharp decline followed by a small rebound. From June 18 to June 26, the price fell consecutively from about HK$ 105, hitting a low of HK$ 88.65 on June 26, with a cumulative decline of over 15%. Then from June 29 to July 03, a technical rebound occurred, rising to a high of about HK$ 97.4 before falling back to HK$ 94.1. The short-term pattern shows a 'sharp decline—rebound—consolidation' structure, with the rebound momentum failing to sustain. Short-term resistance lies near the 10-day MA at HK$ 96.51. If the price cannot effectively hold above this level, the rebound may be declared over, and the risk of moving lower to seek support increases. ### 2. Medium-Term Trend The medium-term trend is clearly bearish. The stock price has broken below both the 20-day and 60-day MAs, and the 20-day MA (HK$ 104.85) continues to decline, with a large gap from the current price level. Looking at the price trajectory, since mid-2025, the stock price has fallen from a high of about HK$ 185 and has now dropped to near a one-year low, with the medium-term downtrend channel remaining intact. ### 3. Trading Volume Analysis - On June 25 and June 26, there was a volume surge during the decline, with trading volumes reaching 141 million and 176 million shares respectively, indicating heavy panic selling sentiment. - On June 29, the rebound day saw a volume of 123 million shares, which was decent, but the following trading days (June 30, July 2, July 3) saw volume shrink significantly to 67-106 million shares, reflecting a lack of willingness to chase highs and insufficient sustained buying support for the rebound. The overall volume pattern is 'volume surges on declines, volume shrinks on rebounds,' which is typically a characteristic of a market dominated by bears. --- ## 4. Investment Recommendations ### 1. Comprehensive Assessment Alibaba is currently in a clear downtrend, but short-term technicals show two potential positive signals: the RSI has entered oversold territory (29.69), and the price has temporarily climbed above the 5-day MA. However, medium-term MAs (20-day and 60-day) still pose significant pressure, and trading volume does not support a trend reversal. Overall, this is assessed as an 'oversold rebound phase within a downtrend,' with no confirmed trend reversal yet. ### 2. Trading Recommendations - **Short-term traders**: Watch for oversold rebound opportunities, but the rebound potential may be limited, with the area above HK$ 96.5 - HK$ 98 acting as strong short-term resistance. It is recommended to trade with a light position and use the recent low of HK$ 88.65 as a stop-loss reference. If this level breaks, the next support looks to the Bollinger Band lower band at HK$ 84.75. - **Medium-to-long-term investors**: It is recommended to stay on the sidelines (Hold) and wait for clear reversal signals before considering phased positioning. Focus on potential golden cross in MACD and whether the price can reclaim above the 20-day MA (HK$ 104.85) as confirmation signals. - **Holders**: If no stop-loss has been set, be aware of the risk of further decline to the Bollinger Band lower band (HK$ 84.75); if holding at a higher cost basis, consider moderately reducing positions when the price rebounds to resistance levels to control risk. ### 3. Key Price Levels - **Strong Support**: HK$ 88.65 (recent low) / HK$ 84.75 (Bollinger lower band) - **Short-term Resistance**: HK$ 96.51 (10-day MA) / HK$ 98.00 (previous high area) - **Medium-term Resistance**: HK$ 104.85 (20-day MA) / HK$ 120.76 (60-day MA) --- **Disclaimer**: This report is for reference only based on technical analysis tools and does not constitute any investment advice. The market carries risks; invest with caution. Please make independent decisions based on your own risk tolerance and fundamental research.

sentiment_report

# 09988 Sentiment Analysis **Stock Type**: Hong Kong Stock **Analysis Date**: July 6, 2026 ## China Market Investor Sentiment China Market Sentiment Analysis Report - 09988 Analysis Date: July 6, 2026 Analysis Period: 7 days 📊 Overall Sentiment Assessment: Market Sentiment: Neutral (Score: 0.00, Confidence: Low) 📰 Financial News Sentiment: - Sentiment Score: 0.00 - Positive News Ratio: 0.0% - Negative News Ratio: 0.0% - Number of News Articles: 1 💡 Investment Recommendations: Based on currently available China market data, investors are advised to: 1. Closely monitor official financial media reports 2. Pay attention to fundamental analysis and financial data 3. Consider the impact of the policy environment on stock prices 4. Monitor international market dynamics ⚠️ Data Notes: Due to API access restrictions on Chinese social media platforms, this analysis is primarily based on publicly available financial news data. It is recommended to combine with other analysis dimensions for a comprehensive assessment. Generated Time: 2026-07-06T09:03:03.868699 --- *Data Source: Automatically selected the most suitable sentiment data source based on stock type*

news_report

Good day, as your professional financial news analyst, I will conduct a detailed news impact analysis on Alibaba (09988) based on the information you have provided. Although there is no latest breaking news at present, I will provide a comprehensive analysis report based on this special 'no news' situation and my professional understanding of Alibaba's fundamentals and market environment. ### Analysis Report: Alibaba (09988) News Impact Analysis **Report Date:** 7/6/2026 **Analyst Note:** This analysis is based on the special situation of "no latest news event." The unavailability of real-time news sources itself is also an important market signal, especially at the critical time point of 09:02, half an hour before the market open. --- ### 1. News Event Summary At the specified analysis time point (7/6/2026 09:02), no latest news related to Alibaba (09988) could be retrieved from any available news sources. * **Event Nature:** Non-event, or "information vacuum." * **Timeliness:** Not assessable due to lack of content. * **Source Reliability:** Temporary unavailability of the external news API service — this is a technical issue and does not reflect the reliability of the news itself. * **Interpretation of This Situation:** Occurring during the pre-market period, this usually implies: * **Expectation of a calm open:** No major positive or negative news overnight that could trigger a gap opening in the stock price. * **Technical interruption:** It may also be a brief data feed failure. Scattered news may exist in the real market but was not captured by the system. ### 2. Impact Analysis on the Stock (09988) Since there is no specific news event, the impact analysis must shift to the potential effect of a "no-news" state on the stock price. * **Short-Term Impact (1-3 days):** * **Lack of Catalyst:** The stock price will rely more on technicals, the broader market trend, and peer performance (e.g., JD.com, Pinduoduo, Tencent). If the broader market is stable, the stock may oscillate within a narrow range, lacking a clear directional breakout. * **Positive/Negative Degree:** Neutral. No additional positive news to boost the price, nor negative news to drag it down. Price reaction will revert to fundamentals. * **Long-Term Impact:** * **Fundamentals Determine Long-Term Trend:** This "no news" event itself has zero impact on the company's long-term investment value. Investors still need to focus on Alibaba's core businesses (cloud computing, e-commerce, international expansion), profitability, share buyback plan, and China's macroeconomic and regulatory environment. * **Risk:** This calm state could be shattered by any sudden financial media report or official announcement not captured in time by the system. The real risk is that the market may feel uneasy about an "information vacuum," especially for a heavyweight stock like Alibaba. * **Impact on Company Fundamentals:** No impact. News is merely an information carrier; it does not change the intrinsic value of the company. * **Key Information Points and Potential Risks:** * **Key Information Points:** None. * **Potential Risks:** The market may be waiting for the next major catalyst (e.g., quarterly earnings, new regulations, management interviews). This waiting itself could lead to shrinking trading volume and reduced volatility. Once sudden news appears, volatility will immediately amplify. * **Historical Comparison of Similar Events:** Historically, on trading days with no major news, individual stocks typically exhibit the following: * **Follow the Broader Market:** The stock price is highly correlated with the Hang Seng Index or the tech index. * **Mean Reversion:** If the previous trading day saw a sharp rise or fall, a technical correction may occur today. * **Shrinking Volume:** Traders lack a clear reason to buy or sell, leading to lower trading volume. ### 3. Market Sentiment Assessment * **Investor Sentiment Change:** **Neutral to Cautious.** The lack of news may make short-term traders feel "bored" or "uncertain" before the open. Long-term investors will remain calmer, waiting for a true catalyst. The no-news market sentiment is typically one of "waiting" and "watching." * **Expected Market Reaction:** A calm open is expected, with the stock price fluctuating within a small range around the opening price. The market will wait for first-hand trading data, order flow, and real-time messages after the open to form a clearer sentiment. * **Confidence Assessment:** Market confidence is in a relatively stable state of uncertainty. No news means no new factors to shake or strengthen confidence. The overall confidence level will be determined by macroeconomic data and overall market risk appetite. ### 4. Investment Advice Based on the situation of "no real-time news," the following conservative and professional trading advice is provided: * **Short-Term Traders:** **Be cautious in opening positions, or opt to wait and see.** With no clear news catalyst, short-term operations are more difficult. It is not recommended to immediately chase highs or sell off at a high risk upon market open when information is insufficient. Focus on price action and trading volume in the first 15-30 minutes after open to gauge the market's true intention. * **Medium-to-Long-Term Investors:** **Maintain existing positions.** A lack of news is not a reason to sell. The no-news state is a good opportunity to review your holding thesis. Focus on the company's fundamentals, valuation (such as P/E Ratio, P/B Ratio), and buyback progress. If the stock price experiences a "low-volume decline" due to no news, it is an opportunity to accumulate in batches on dips. * **Risk Management:** Set stop-loss levels below technical support levels (e.g., recent lows or important moving averages). Be aware that a news API outage does not equal a market outage; be sure to check other financial media sources (such as Reuters, Bloomberg, Sina Finance) independently to confirm whether any major news has been missed. * **Strategy Summary:** **"Respond to change with stillness."** In the absence of clear signals, the best strategy is to reduce trading frequency. --- ### Summary Table | Analysis Dimension | Key Findings | Impact Assessment | | :--- | :--- | :--- | | **News Event** | **No real-time news (data retrieval failure)** | Neutral, information vacuum | | **Short-Term Stock Impact (1-3 days)** | Lack of catalyst, stock will follow broader market and technicals | Slightly negative (unfavorable for short-term traders), sideways oscillation | | **Long-Term Investment Value** | No impact, fundamentals remain core | Neutral, need to continue monitoring earnings and strategic progress | | **Market Sentiment** | **Neutral to Cautious**, strong wait-and-see atmosphere | Market in waiting mode, volatility expected to decrease | | **Key Risk** | Sudden news may cause sharp intraday volatility; API outage may hide uncaptured news | High, need to independently supplement multi-channel information | | **Bullish Level** | 0 / 10 (No Event) | - | | **Bearish Level** | 0 / 10 (No Event) | - | | **Comprehensive Investment Advice** | **Short-term: Wait and see or light positions; Medium-to-long-term: Maintain positions, focus on fundamentals** | - | | **Trading Priority** | **Low** - Lack of clear trading signal | Suggest waiting for more definite price action or news event |

fundamentals_report

# 📊 Alibaba (09988) In-Depth Fundamental Analysis Report **Analysis Date**: July 6, 2026 **Stock Ticker**: 09988 (HK Stock) **Latest Stock Price**: HK$94.10 **Data Source**: Real Market Data --- ## I. 🏢 Company Overview and Financial Data Analysis ### Core Financial Data (Latest Reporting Period: 2026-03-31) | Item | Value | |------|------| | **Revenue** | **10,236.70 billion HKD** | | Revenue YoY Growth | +2.74% | | **Net Profit Attributable to Shareholders** | **1,035.92 billion HKD** | | Net Profit YoY Growth | **-20.38%** | | Basic EPS | HK$5.70 | | Rolling EPS (TTM) | HK$4.74 | | Book Value Per Share (BPS) | HK$55.64 | | Operating Cash Flow Per Share | HK$3.98 | ### Profitability Metrics | Metric | Value | |------|------| | Gross Margin | **39.81%** | | Net Margin | **9.98%** | | ROE (Return on Equity) | **9.91%** | | ROA (Return on Assets) | **5.58%** | ### Financial Health | Metric | Value | Rating | |------|------|------| | Debt-to-Asset Ratio | **41.02%** | ✅ Stable | | Current Ratio | **1.28** | ✅ Good short-term solvency | **Analysis Highlights**: - Alibaba's annual revenue exceeds **1 trillion HKD**, with massive scale and strong cash flow - However, net profit **declined 20.38% YoY**, reflecting macroeconomic pressure and increased competition impacting profitability - ROE maintained at **9.91%**, a reasonable level but clearly down from historical highs --- ## II. 📈 Valuation Metrics Analysis ### P/E Ratio | Item | Value | |------|------| | **Current P/E** | **19.83x** | | Calculation | Current Price HK$94.10 ÷ EPS_TTM HK$4.74 | | Industry Comparison | HK tech leaders reasonable range is about 15–25x | > 📌 **Interpretation**: A P/E of 19.83x is at a reasonably low level. Given Alibaba's market leadership and trillion-level revenue, this valuation is not expensive. ### P/B Ratio | Item | Value | |------|------| | **Current P/B** | **1.69x** | | Calculation | Current Price HK$94.10 ÷ BPS HK$55.64 | > 📌 **Interpretation**: P/B of only **1.69x** is in the historically low range. For a tech giant with core assets in cloud computing, e-commerce, logistics, and local services, this valuation is clearly low. ### PEG Analysis (Growth-Adjusted P/E) - Revenue growth rate: +2.74% (stable) - Profit growth rate: **-20.38% (negative growth)** - **PEG not applicable** (traditional PEG invalid due to negative profit growth) > ⚠️ The profit decline is the core reason for current valuation suppression. Focus on whether profits can stabilize and recover. --- ## III. 🔍 Is the Current Stock Price Undervalued or Overvalued? ### Technical Analysis | Indicator | Value | Signal | |------|------|------| | MA5 (5-day MA) | HK$92.79 | Price slightly above short-term MA | | MA10 (10-day MA) | HK$96.51 | ⬇️ Price below 10-day MA, short-term weak | | MA20 (20-day MA) | HK$104.85 | ⬇️ Price well below 20-day MA | | MA60 (60-day MA) | HK$120.76 | ⬇️ Price well below 60-day MA | | **RSI(14)** | **29.69** | 🔴 **Oversold zone (<30)** | | Bollinger Lower Band | HK$84.75 | Price near lower band support | | Bollinger Middle Band | HK$104.85 | Midline resistance | | 52-Week High | HK$184.57 | Current price **down ~49%** from high | | 52-Week Low | HK$88.65 | Current price only **+6.1%** above low | ### Comprehensive Valuation Assessment | Valuation Method | Result | Assessment | |----------|----------|------| | P/E (19.83x) | Historical median ~25x | Low | | P/B (1.69x) | Historical median ~3-4x | **Significantly undervalued** | | Price / Cash Flow Per Share | HK$94.10 / HK$3.98 = 23.6x | Reasonable | | Price vs 52-Week Low | Only 6.1% above | Near bottom area | **Conclusion**: Alibaba's current stock price is **in an undervalued range**, especially from a P/B perspective. A P/B of 1.69x provides a clear margin of safety for a tech giant with such a high-quality asset portfolio. --- ## IV. 🎯 Fair Value Range and Target Price Recommendations ### Estimated Fair Value Range | Valuation Basis | Valuation Multiple | Corresponding Fair Price | |----------|----------|-------------| | **P/E (Conservative)** | 18–22x | **HK$85.3 ~ HK$104.3** | | **P/E (Neutral)** | 20–25x | **HK$94.8 ~ HK$118.5** | | **P/B (Conservative)** | 1.5–2.0x | **HK$83.5 ~ HK$111.3** | | **P/B (Neutral)** | 2.0–2.5x | **HK$111.3 ~ HK$139.1** | ### Target Price Recommendations | Target Type | Price (HK$) | Description | |----------|-------------|------| | **Short-term Support** | **HK$85 ~ HK$89** | Near Bollinger lower band and 52-week low | | **Current Fair Value Center** | **HK$95 ~ HK$110** | Neutral P/E/P/B valuation range | | **Medium-term Target** | **HK$110 ~ HK$120** | Between Bollinger middle band and MA60 | | **Long-term Target** | **HK$130 ~ HK$150** | Valuation recovery to historical median level | --- ## V. 💡 Investment Recommendations Based on Fundamentals ### ✅ Overall Rating: **Hold** | Rating Dimension | Score | Description | |----------|------|------| | Valuation Attractiveness | ⭐⭐⭐⭐⭐ | P/B 1.69x at historical low, ample margin of safety | | Profitability | ⭐⭐⭐ | ROE 9.91% acceptable, but net profit decline needs monitoring | | Financial Health | ⭐⭐⭐⭐ | Debt-to-asset ratio 41%, current ratio 1.28, financial stability | | Growth Outlook | ⭐⭐⭐ | Revenue still positive, but profit recovery timing uncertain | | Technicals | ⭐⭐⭐ | RSI oversold may brew a rebound, but moving averages bearish | ### Specific Action Suggestions **🔹 Current Holders**: - **Recommend 'Hold'**, current price in bottom area, do not sell at a loss - Consider **averaging down** in the HK$85–90 range to lower cost basis **🔹 Investors Not Yet Positioned**: - **Recommend building position in batches** - First buy zone: **HK$88–92** (near technical support) - Second buy zone: **HK$84–88** (near Bollinger lower band) - **Stop-loss**: Reassess if price breaks below HK$80 (approx. -15%) **🔹 Target Price and Return Expectations**: - Short-term (1–3 months): Target **HK$105–110**, potential return **+11%–17%** - Medium-term (6–12 months): Target **HK$120–130**, potential return **+27%–38%** ### ⚠️ Key Risk Warnings 1. **Macroeconomic pressure**: Consumer recovery below expectations may impact e-commerce business 2. **Intensified competition**: Pinduoduo, Douyin e-commerce continue to capture market share 3. **Profit decline trend**: Net profit down 20.38% YoY, closely monitor next quarter for stabilization 4. **Regulatory uncertainty**: Platform economy policies remain variable --- ## 📋 Summary | Item | Conclusion | |------|------| | Current Price | HK$94.10 | | Valuation Status | **Undervalued** (P/B at historical low, P/E reasonably low) | | Fair Value Range | **HK$95 ~ HK$110** | | Short-term Target | HK$105 ~ HK$110 | | Medium-term Target | HK$120 ~ HK$130 | | Investment Recommendation | **Hold** (accumulate on dips in batches) | > 💬 **Analyst Comment**: Alibaba (09988) is currently in a low valuation range from both P/E and P/B perspectives, with a P/B of just 1.69x reflecting the market's pessimistic view of its growth prospects. However, the company still possesses strong cash flow, a solid balance sheet, and over one trillion HKD in revenue. Technically, RSI(14) at 29.69 has entered oversold territory, increasing the probability of a short-term rebound. Existing investors are advised to continue holding, while new investors may consider building positions in batches in the HK$85–92 range, awaiting a valuation recovery rally.

investment_plan

Alright, everyone. After a comprehensive review of the debate on Alibaba (09988), I must now give a clear and actionable decision: **Sell**. This decision is not easy, especially when a company's stock price has already been cut in half and its P/B ratio looks to be only 1.69x. But looking back at my past mistakes, the most expensive lesson was exactly that — "thinking something is cheap just because the stock price has dropped a lot, then buying too early and falling into a value trap." This time, I cannot let the same mistake repeat. Next, I will strictly follow the symmetrical decision criteria and explain one by one why Buy is rejected, why Hold is rejected, and why Sell is ultimately chosen. --- ### ❌ Why Not Buy? The core of a bull analyst's argument is "low valuation" and "oversold bounce." But these arguments, in the face of current evidence, cannot convince me. First, his so-called "margin of safety" — **P/B of 1.69x** — amid a profit plunge is not a signal of undervaluation, but rather **the market's rational pricing of earnings decline**. Fundamentals show that Alibaba's net profit dropped 20.38% year-over-year, while revenue growth was almost stagnant at just 2.74%. Behind the low P/B is an ROE of only 9.91%, and this return rate does not provide strong momentum for revaluation. If profits continue to decline, net assets per share may also be eroded, and a 1.69x P/B will become a moving target with no real margin of safety. Second, the "oversold" cries on the technical side ignore the power of the trend. The RSI of 29.69 has indeed entered oversold territory, but the stock price is clearly below the MA10, MA20, and MA60 — a classic **bearish arrangement**. Most deadly is the trading volume: heavy volume on down days (141 million and 176 million shares on June 25 and 26, respectively), but sharply shrinking volume on rebounds (only 67 million shares on July 3). This is not exhaustion of the bears, but rather the bulls failing to organize an effective counterattack. Trying to catch a rebound in such a trend is like catching a falling knife — extremely risky. Finally, the market lacks any catalyst. News analysis shows an information vacuum and neutral sentiment. No new story, no policy tailwinds, no earnings surprise — what will drive the stock price up? Faith in "valuation repair" is not enough; real buying power is needed. And right now, buying power is clearly insufficient. Therefore, the evidence for buying is completely insufficient to outweigh the bearish evidence. I cannot recommend a Buy just because it "looks cheap." --- ### ❌ Why Not Hold? Holding means the bullish and bearish arguments are evenly balanced, but what I see is a clear tilt. The bearish side provides specific and mutually reinforcing evidence: structural decline in profits, stagnant revenue, a confirmed bearish technical trend with weak rebounds. These facts form a clear logical chain — deteriorating fundamentals are driving the stock price down, and the technicals fully align with this trend. In contrast, the bullish arguments are mainly "low valuation" and "oversold may brew a rebound," but these are vague possibilities lacking specific catalysts, and under the bear analyst's data rebuttal, they appear fragile. If I now say "both sides have points" and choose to Hold, I would be abdicating my responsibility as a portfolio manager to make a judgment. The current situation is not a mixed signal that is hard to analyze, but rather a clear and urgent downside risk. Therefore, holding does not meet the strict standard of "bulls and bears exactly canceling out" and must be rejected. --- ### ✅ Why Sell? The evidence for selling overall outweighs the bullish arguments. The following three points are the cornerstone of my decision: 1. **Fundamental deterioration is structural, not a temporary pain.** Net profit down 20.38%, revenues nearly stagnant — these two data points cannot be fully explained away by "increased strategic investment." They reflect Alibaba's continuous loss of market share in core e-commerce to Pinduoduo and Douyin e-commerce, while macro consumer weakness further suppresses growth. For a giant with trillion-dollar revenue, if the growth engine stalls, the market will quickly shift from "growth stock valuation" to "value stock or even decline stock valuation." The current 19.83x P/E is based on past earnings that have not yet fully reflected the downward trend; there is no margin of safety. 2. **Technical indicators send a clear signal of sustained downtrend.** The bearish arrangement of moving averages and volume structure (heavy on down days, light on rebounds) indicate institutional money is exiting while retail traders try to bottom-fish but are unable to turn the tide. RSI oversold can persist for a long time in a strong trend; this is not a reason to buy, but a warning not to go against the trend. The stock price still has room to the lower Bollinger Band of HKD 84.75, and the recent low of HKD 88.65 is likely not the bottom. 3. **Lack of any visible short- or medium-term catalysts.** Information vacuum, neutral sentiment, no major news — this shows the market is indifferent to this stock, and new funds will not rush in. Under such circumstances, the only direction for the stock price is along the path of least resistance, and currently that path is downward. In summary, the risk of continuing to hold or buy far outweighs the opportunity. Selling is the clearest decision based on the available evidence. --- ## 📊 Investment Plan and Target Price Analysis ### 🎯 My Recommendation: Sell Alibaba (09988) **Rationale**: The fundamental profit decline and technical bearish trend are reinforcing each other. The valuation appears cheap but is actually a reasonable reflection of declining earnings, and there is a complete lack of any short-term catalyst to reverse the slump. The downtrend is clear, and holders face further principal loss risk. ### 📈 Strategic Actions - **For current holders**: Recommend using any small bounce (e.g., when it struggles toward the HKD 96-98 area) to start reducing positions and not to linger. If the stock price directly breaks below the recent low of HKD 88.65, decisively execute a stop-loss and pull out capital. - **For those with no position or those looking to short**: Can establish a short position around HKD 94, with an initial stop-loss above HKD 98 (i.e., above the MA10 resistance zone in the bearish arrangement). Target the technical support levels below. - **Risk management**: Strictly control position size. Do not relax the stop-loss just because "the stock has already dropped a lot." Remember my lesson — **never assume there is no room to fall just because the price has dropped**. ### 💰 Target Price Analysis (Based on Data in the Report) I will extract key price levels from the report to construct conservative, baseline, and optimistic scenarios. But please note, our decision is to sell, so the focus is on the reasonableness of the downside targets. - **Conservative scenario (sell target, 1 month)**: **HKD 84.75**. This is the lower Bollinger Band from the technical analysis report, and the most direct support after the recent high-volume decline. Given bearish momentum, reaching this level within one month is highly likely. - **Baseline scenario (3-month target)**: **HKD 83.50 – HKD 85.00**. The conservative P/B valuation in the fundamental report is 1.5x, corresponding to a stock price of approximately HKD 83.5 (BPS 55.64 × 1.5). If the market further prices in profit decline, this will be a reasonable value-return level. At the same time, this range overlaps with the lower Bollinger Band, forming dual support from technicals and valuation. - **Optimistic scenario (6-month slowdown in decline)**: **HKD 80.00**. This figure comes from the "stop-loss level" reference in the fundamental report — reassess if it breaks below HKD 80. I take this as a risk-adjusted target under extreme bearish sentiment. If future financial reports show further profit declines, the 1.69x P/B cannot hold, and the stock price may seek a bottom here. Time frames and specific targets: - **1-month target price: HKD 84.75** (lower Bollinger Band) - **3-month target price: HKD 83.50** (conservative P/B valuation) - **6-month target price: HKD 80.00** (risk-adjusted extreme value) Please do not misunderstand — I am not saying Alibaba will go bankrupt. It is still a giant with strong cash flow and a solid balance sheet. But as traders, we trade the future direction of the stock price, not the survival of the company. Under all currently available evidence, the path downward is clearer and more likely than the path upward. Therefore, selling is the most reasonable action at this moment.

trader_investment_plan

## 📊 Trading Decision Based on Professional Analysis ### 1. Investment Recommendation: **Sell** **Reason**: - Alibaba (09988) fundamentals show structural deterioration: net profit decreased 20.38% YoY, revenue growth only 2.74%, indicating core business market share erosion and macro consumer weakness suppressing growth. - Technicals clearly show bearish alignment: stock price below MA10/MA20/MA60, declining on rising volume while rallies on declining volume, RSI 29.69 oversold but no reversal signal, Bollinger lower band (HK$84.75) still has room to fall. - Lack of short-term catalysts: news vacuum, neutral sentiment, no policy or earnings surprises to drive capital inflows. - Valuation trap risk: 1.69x P/B appears cheap, but ROE only 9.91%; if profits continue to decline, book value per share may be eroded, no margin of safety. ### 2. Target Price (HKD HK$) | Scenario | Target Price | Timeframe | Basis | |------|--------|----------|------| | **Conservative (Sell target)** | **HK$84.75** | 1 month | Technical: Bollinger lower band, most immediate support after recent decline on volume | | **Baseline (Reasonable downside)** | **HK$83.50** | 3 months | Fundamental: Conservative P/B valuation 1.5x (BPS 55.64 × 1.5), technical overlap with Bollinger lower band | | **Optimistic (Extreme adjustment)** | **HK$80.00** | 6 months | Fundamental: Risk-adjusted value from report that triggers reassessment below HK$80, corresponding to extreme bearish sentiment | - **Current price approximately HK$93.0**, downside potential of approximately 9%–14%. ### 3. Confidence Level: **0.85** (High Confidence) - Fundamentals, technicals, and news flow all align bearish, evidence chain is clear and mutually corroborative, with a clear downward path. ### 4. Risk Score: **0.70** (Medium-High Risk) - Main risk: short-term oversold may trigger a technical bounce (e.g., back to HK$96–98), but reversal requires a strong catalyst, currently absent. - If the stock price breaks below HK$88.65 (recent low), it may accelerate downside to below HK$84.75. - Suggest strict stop-loss; do not relax risk management just because "the stock has already fallen a lot". ### 5. Detailed Reasoning - **Fundamentals**: Profit decline 20%+ and revenue stagnation reflect intensifying competition and macro headwinds; growth stock valuation logic collapses, shifting to distressed stock pricing. 19.83x P/E without margin of safety. - **Technical**: Bearish alignment + price-volume divergence (decline on volume, rally on low volume) indicates institutional capital flowing out, retail buying the dip unable to absorb. RSI oversold in a strong trend can persist; not a reason to buy. - **Sentiment**: Market neutral and indifferent, lack of incremental capital, stock price moves along the path of least resistance (downward). - **Lessons Learned**: In the past, I have bought too early thinking "it has fallen a lot so it must be cheap" and fell into a value trap. This time I must avoid repeating that mistake. Selling is the most rational decision given the available evidence. --- **Final Trading Recommendation: Sell**

final_trade_decision

Alright, as the Chairman of the Risk Management Committee and the moderator of this debate, I have carefully weighed the intense exchanges among the three analysts, incorporating the valuable lessons learned from the Research Manager's past mistakes. My goal is to provide traders with a decision that is well-evidenced, logically rigorous, and immediately actionable. Now, I deliver the final ruling. --- ### 🎯 Final Decision: Sell Alibaba (09988) This decision confirms and supports the Research Manager's initial judgment. After a comprehensive review of the debate, especially the symmetrical rejection of the Buy and Hold options, Sell is the only course of action consistent with the current weight of evidence and risk management discipline. --- ### ❌ Why Reject Buy? The aggressive analyst's core argument — "Extreme pessimism is already priced in, and the market is at a point of extremely asymmetric risk-reward" — sounds appealing but does not withstand rigorous scrutiny of the evidence. His entire bullish narrative is built on a castle of sand: **"The profit decline is a strategic investment."** As the safety analyst sharply pointed out, **this assumption has no data support in the existing reports.** The report shows a 20.38% year-on-year decline in net profit but does not indicate that the funds are flowing into projects that will generate future returns. Attributing the profit plunge to strategic investments is pure speculation, not fact-based analysis. We cannot commit company capital to an unsubstantiated story. Second, the "margin of safety" he relied on — a PB of 1.69x — was jointly debunked by the neutral and safety analysts as a potential **value trap**. The core issue is that ROE is only 9.91%. An asset with a low PB, but accompanied by low ROE and declining profits, has its low valuation as a rational market reflection of deteriorating profitability, not a mispricing. If profits decline further, book value per share will also be eroded, and the 1.69x PB will then correspond to an even lower absolute stock price. As the Research Manager learned from his costly lesson: **"Thinking a stock is cheap because it has fallen a lot, then buying too early, only to fall into a value trap."** The aggressive analyst's advice is precisely luring us to repeat that mistake. On the technical side, the aggressive analyst interprets a "slight narrowing of the negative MACD" and "a rebound on declining volume" as precursors to a reversal — a highly dangerous misreading. Against the clear bearish alignment (price below MA10, MA20, MA60) and the pattern of "declining on volume, rebound on shrinking volume," a more accurate interpretation of these signals is: **Selling pressure has temporarily eased, but buying on dips is even scarcer, and the market lacks endogenous momentum to reverse the trend.** This is not an "eye of the storm" but a sign of weakening bullish power. Buying against the trend before clear technical reversal signals appear (e.g., consecutive closes above key moving averages, a MACD golden cross) is nothing short of catching a falling knife with bare hands. Therefore, the case for Buy is built on unsubstantiated assumptions and an erroneously optimistic interpretation of technical signals, carrying extremely high and uncontrollable risk. I must reject this option. --- ### ❌ Why Reject Hold? The neutral analyst's plan to "reduce half the position and retain the other half" sounds like a rational middle ground at first, but under rigorous symmetrical argumentation, it exposes its strategic flaw — an attempt to have it both ways that could end up falling between two stools. The premise for holding or partially holding is that the bullish and bearish arguments are so evenly balanced that no directional judgment can be formed. However, the current weight of evidence is not like that. We see a clear and mutually reinforcing chain of bearish logic: - **Fundamentals:** Structural profit decline (-20.38%), stagnant revenue growth (+2.74%). - **Technical:** Price is in a textbook bearish alignment, with a rebound on declining volume indicating insufficient buying. - **Market Sentiment & Catalysts:** An information vacuum, lacking any short- or medium-term catalysts that could reverse the downturn. In contrast, the bullish arguments rest on vague possibilities such as "it has already fallen a lot" and "valuation is already low," which have been effectively refuted by the safety analyst. Given this clear and urgent downside risk, retaining half the position means we are voluntarily assuming a 50% exposure to explicit downside risk (with the stock price sliding toward HK$84.75 or even HK$80) in exchange for a vague and unsupported upside potential. The neutral analyst's set trigger for adding positions — "the stock price closes above the 10-day moving average for two consecutive days and MACD turns positive" — precisely confirms the passivity of the hold strategy: by the time these signals appear, the stock price would already have departed from the bottom, forcing us to chase at a higher cost, effectively achieving a "sell low, buy high." As the Research Manager said: "If I now say 'both sides have a point' and choose to hold, I am abdicating my judgment responsibility as a portfolio manager. The current situation is not a mixed signal that is hard to analyze; the downside risk is clear and urgent." The neutral analyst's plan is essentially postponing the "responsibility of judgment" into the future while exposing assets to unnecessary risk in the present. This is not risk management; it is risk procrastination. Therefore, I must reject the Hold option. --- ### ✅ Why Sell? — Consistent with the Research Manager's Judgment My risk assessment fully confirms the Research Manager's judgment. The evidence for selling overwhelmingly outweighs all opposing views, and its foundation has not only withstood refutation but has been further strengthened through the debate. 1. **Fundamental deterioration is the core driver:** The combination of a 20.38% profit decline and near-stagnant revenue is the root cause triggering a chain reaction in valuation and technicals. This is not a temporary pain but a dual signal of market share erosion and a weak macro environment. The safety analyst's view is decisive: **Without clear evidence that profits have bottomed and rebounded, we must assume the decline trend will persist.** This is a basic discipline for capital preservation, not excessive pessimism. 2. **Technicals and fundamentals resonate:** The bearish alignment of moving averages and the volume structure of "declining on volume, rebound on shrinking volume" are perfect reflections of fundamental deterioration in market trading. These technical signals tell us that smart money is exiting, while retail buying on dips lacks the scale to form a meaningful countertrend. This is not a bottoming pattern; it is a process of continued search for a bottom. 3. **The risk of a "valuation trap" far outweighs the opportunity for "valuation repair":** This is the most critical risk insight from the discussion. A low PB cannot be a reason to buy because it reflects the reality of low ROE and profit decline. The principle of "avoiding value traps" distilled by the Research Manager from his own costly lessons is our strongest shield against the aggressive analyst's allure. The safety analyst further pointed out that "asset replacement cost" is ineffective when profitability is declining, completely dismantling the bulls' last fortress. 4. **Lack of catalysts means the path of least resistance is downward:** In a vacuum of positive narratives, policies, and earnings surprises, the only direction for the stock price is along the existing bearish trend. Waiting for a catalyst itself carries a cost, and the current market tells us that such waiting is likely to result in further stock price declines. In summary, the reasons to reject both Buy and Hold are clear and overwhelming. Sell is the only reasonable choice based on all available evidence, risk assessment, and deep reflection on past mistakes. This is not panic; it is discipline. --- ### 📈 Refined Action Plan The trader's original plan is already sufficiently robust; I have only fine-tuned and confirmed it based on the views from the debate. - **For existing holders:** Agree to use any minor rebound toward the `HK$96-98` area to begin reducing positions. If the price directly breaks below the recent low of `HK$88.65`, a decisive stop-loss must be executed without hesitation. This is key to preventing larger losses like a frog slowly boiled in water. - **For those who are short or want to go short:** Agree to establish a short position near `HK$94`, with a stop-loss set above `HK$98`. This is trading in the direction of the bearish trend. The target is clearly the technical support level below at `HK$84.75`. - **Risk Management Discipline:** Reiterate the Research Manager's lesson — "Never assume there is no room for further decline just because the price has fallen." Low valuation alone is not a reason to buy, especially when profitability is deteriorating. Strictly implementing stop-losses is the most important lesson we have learned from past mistakes. ### 💰 Target Price Analysis (Confirmed) - **1-month Target Price: HK$84.75** (from technical analysis of the lower Bollinger Band, the most immediate downside target) - **3-month Target Price: HK$83.50** (from the conservative PB valuation in the fundamentals report, overlapping with the lower Bollinger Band, forming a strong support zone) - **6-month Target Price: HK$80.00** (as a risk-adjusted target in an extreme bearish scenario; if the profit decline intensifies, PB valuation will shrink further) --- ### 🔄 Comparison with the Research Manager's Decision: Confirmation of Alignment My final decision is **fully consistent** with the Research Manager's initial judgment. My risk assessment process systematically tested and confirmed his judgment. This debate has not only failed to overturn but has strengthened the sell conclusion. The reasons are as follows: 1. **The core risk — the "value trap" — has been thoroughly confirmed:** The aggressive analyst not only failed to prove Alibaba's "undervaluation" but his argument was successfully dismantled by the safety analyst's data showing that "an ROE of only 9.91% cannot support the appeal of a low PB." This directly validates the Research Manager's intuition to avoid repeating past mistakes. 2. **Opposing views lack evidentiary support:** All key bullish and neutral assumptions — that profit decline is strategic investment and that the technicals are about to reverse — were pointed out in the debate as lacking support from report data. These unsubstantiated assumptions are exactly the "faith-based investing" that the Research Manager initially sought to avoid, and my review process successfully filtered them out. 3. **The clarity of downside risk is confirmed:** The safety analyst's interpretation of technical and fundamental deterioration (such as the risk of "catching a falling knife" and a "dead cat bounce") is not only irrefutable but resonates with the Research Manager's view that "declining on volume and rebounding on shrinking volume indicates weakening bullish power," together forming a complete bearish picture. Therefore, my ruling is not merely support for one view, but a confirmation of an entire evidence-based risk management discipline. In the current trade on Alibaba, selling is not conservatism; it is clarity.

bull_researcher

Bull Analyst: Dear investors, allow me, as a staunchly bullish analyst, to present a strong, evidence-based, and logically rigorous argument for Alibaba (09988). The pervasive pessimism in the market, in my view, is precisely the golden opportunity for rational investors to uncover excess returns. Today, I will dismantle the current bearish arguments one by one and demonstrate why Alibaba's future is far brighter than the stock price reflects. First, we must directly confront a core issue: the stock price has fallen nearly 50% from its high (from HK$184.57 to HK$94.10), the technical indicators show a bearish arrangement, and net profit declined 20.38% year-over-year. All of this indeed looks discouraging. But **true value investing is precisely about buying quality assets at a price below intrinsic value when the market is most pessimistic.** Let's start with the most compelling entry point: valuation. According to the **Fundamentals Report**, Alibaba's **P/E (Price-to-Earnings) ratio is 19.83x**, while its **P/B (Price-to-Book) ratio is only 1.69x**. Bearish friends will say, "Profits are declining, so P/E is meaningless." — I disagree. P/E is calculated based on earnings over the past 12 months (EPS_TTM HK$4.74). **A P/E of 19.83x for a tech giant with annual revenue exceeding HK$1 trillion and gross margins near 40% is already at a reasonably low level.** More importantly, **the P/B of 1.69x** — this is nearly an all-time low. This means the market is pricing Alibaba's entire business empire, including its core Taobao and Tmall e-commerce, Alibaba Cloud, Cainiao Logistics, Ele.me local services, and other premium assets, at less than 1.7 times net asset value. If this were an ordinary company, a 1.69x P/B might be reasonable, but this is Alibaba! At this point, bearish analysts may counter: "But the 20% profit decline is a fact; you cannot ignore this warning sign." I fully agree that the profit decline warrants attention, but we need to view it dialectically. Behind the profit decline is Alibaba's strategic transformation — the company is increasing investment in new businesses such as cloud computing, international expansion, and local services, all of which require short-term profit sacrifices. However, **the Fundamentals Report also points out that the company's revenue still maintained positive growth (+2.74%), indicating that market demand has not disappeared; only the income statement is under pressure.** Once investments enter the return phase, profit elasticity will be considerable. Moreover, **the Fundamentals Report shows a debt ratio of only 41.02% and a current ratio of 1.28, indicating extremely sound financial health.** A trillion-revenue giant with strong cash flow and low debt is well-positioned to weather any short-term adjustment. Next, let's look at the technical picture. The current technical report indeed shows a "bearish" landscape: the stock price is below all major moving averages, and the MACD is negative. But savvy investors know that **extreme pessimism often heralds an approaching turning point.** The key signal comes from the **RSI (Relative Strength Index)**. According to the **Technical Analysis Report**, **RSI(14) has fallen to 29.69, clearly entering "oversold" territory.** Historically, when a fundamentally sound leading stock's RSI drops below 30, it often indicates that short-term panic has been exhausted, a strong precursor to a technical rebound. The volume pattern of "down on heavy volume, up on light volume" may seem weak, but light volume on rebounds also suggests that bearish momentum is fading, not accumulating new downward force. The stock price is currently only about 10% above the lower Bollinger Band (HK$84.75), providing a clear risk floor for bulls. Bearish counterparts may also cite the **Social Sentiment Report's** "neutral" rating to support their view. But note that the report explicitly states that sentiment data sources are limited, with only 1 news item and "low" confidence. In an information vacuum, the market tends to be tepid due to the lack of catalysts, but **for value investors, this calm "no-news" condition is often the best time to accumulate positions, not a reason for panic.** Let's return to a more fundamental competitive advantage. Alibaba's moat is not just e-commerce, but its **"Commercial Operating System"** . From payments (Ant Group), logistics (Cainiao), cloud computing (Alibaba Cloud) to local services, it has built a digital ecosystem that is nearly impossible to replicate. This ecosystem creates significant network effects and high user switching costs. Bears worry about competition from Pinduoduo and Douyin, but China's e-commerce market is still growing, and Alibaba's absolute scale and brand trust remain unmatched. As the leader in China's cloud computing market, Alibaba Cloud has immense long-term growth potential. Finally, I must address a crucial reflection: **What have we learned from past mistakes?** In the past few years, market concerns about Alibaba (regulation, macro, competition) were not unfounded, but the stock price decline has far exceeded the deterioration in fundamentals. When Alibaba's stock was at HK$150-180, many told you "this is a reasonable valuation"; when it fell to HK$100, the same people started saying "there is still room to fall." **The lesson I have learned is to buy bravely when the market is most panicked and valuations are cheapest, not to chase when prices are rising and the story is rosy.** Now, **with a P/B of only 1.69x**, the market is pricing a company that earns over HK$100 billion annually at "bankruptcy prices" — this in itself is a massive mispricing. If we fear the decline that has already happened and miss the opportunity to buy a top-tier enterprise at a discount, that would be the true mistake. **In summary, my view is clear and steadfast:** 1. **Valuation is highly attractive**: P/E of 19.83x is reasonably low, P/B of 1.69x is at an extreme historical low, providing ample margin of safety. 2. **Technical indicators show oversold conditions**: RSI of 29.69 suggests a short-term rebound is brewing, offering an opportunity to position on dips. 3. **Fundamentals remain strong**: Trillion-dollar revenue, solid balance sheet, ecosystem moat unchanged. 4. **Market sentiment is extremely pessimistic**: This is a classic moment for contrarian investing. Bearish analysts, please present your data and logic to convince me. Do you believe Alibaba's net profit decline is permanent? Do you think the 1.69x P/B reflects its true asset value? Or are you merely swept up by short-term market sentiment? Investing in Alibaba (09988) now requires confidence in the long-term development of China's economy and business model, and patience to look beyond short-term fluctuations. This is a feast for value discoverers.

bear_researcher

Bear Analyst: Alright, investors, thank you to the Bullish Analyst for painting a beautiful picture of Alibaba (09988) waiting to be discovered in a “value trough”. I am the Bearish Analyst, and my task is not to deny all possibilities, but to use data and logic to put on a “risk lens” for you, to see the thorns and traps hidden behind this “feast”. Let us directly address the Bullish Analyst’s core arguments: “low valuation” and “oversold bounce”. He repeatedly emphasizes that the **P/B of 1.69x** is at a historical low, a “bankruptcy price”. But I want everyone to consider a key question: **Does a low P/B mean assets are undervalued? Or does it reflect the market’s rational expectation of declining future profitability of these assets?** **First, structural decline masked by a low P/B.** According to the **Fundamentals Report**, Alibaba’s **net profit year-over-year growth is -20.38%**. This is not a short-term “strategic investment”, but a very significant signal of profit decline. The Bullish Analyst attributes this to “increased spending”, but we must see that when a giant with revenue exceeding HKD 1 trillion faces brutal diversion from new forces like Pinduoduo and Douyin (TikTok) e-commerce, such “investment” is more like “stopping the bleeding” rather than “expansion”. Revenue growth is only **+2.74%**, nearly stagnant, indicating that Alibaba’s market share is being eroded and its growth engine has stalled. **A P/B of 1.69x is not a market mistake, but the market repricing a “mature enterprise with declining profitability”.** If profits continue to decline, the EPS of HKD 4.74 will no longer be sustainable, and the P/E will then be passively elevated, and the so-called “undervaluation” will no longer exist. **Second, the bearish technicals reflect a trend, not a sentiment illusion.** The Bullish Analyst excitedly points out that the RSI at 29.69 has entered oversold territory, considering this a precursor to a rebound. But look at the key data in the **Technical Analysis Report**: the stock price is **HKD 94.10**, clearly below **MA10 (HKD 96.51)**, **MA20 (HKD 104.85)**, and **MA60 (HKD 120.76)**. This is a standard “bearish alignment”, and the trend is very clear: the pressure from the mid-term (20-day moving average) and long-term (60-day moving average) is immense, and the stock price needs extremely strong buying momentum to break through these resistances. Look at the trading volume: **on June 25 and 26, the stock fell on high volume** (141 million and 176 million shares respectively), indicating institutional funds were decisively exiting; while **rebounds occurred with shrinking volume** (for example, on July 3 only 67 million shares), showing very low market participant conviction in the rebound. This is not “bearish power exhaustion”, but “bulls are simply unable to counterattack”. In a strong downtrend, the RSI can linger in oversold territory, even become oversold again after being oversold; **trying to “catch the falling knife” is extremely risky.** **Third, refuting the optimistic hypothesis of an “ecosystem moat”.** The ecosystem of “payments, logistics, cloud computing” mentioned by the Bullish Analyst appears unbreakable. But we must ask: are the growth drivers of this ecosystem synchronized? Based on available data, we cannot see the specific growth figures for Alibaba Cloud, but the continuous decline in its stock price itself indicates the market’s concern about this segment. More importantly, against the backdrop of macroeconomic slowdown and consumption downgrade, the e-commerce business is the first to be affected. The **Social Media Sentiment Report** shows market sentiment as “neutral”, and the number of news articles is extremely low, which in the information age is itself a negative signal – the market lacks new stories and catalysts for this company. When a company with trillion-level revenue loses the market’s imagination, its valuation can only align with utility stocks, not technology growth stocks. **Finally, directly responding to the Bullish Analyst’s argument about “learning from past mistakes”.** You call on investors to buy during panic, but shouldn’t the lesson we learn be “don’t blindly buy just because the stock has fallen a lot”? The real mistake we need to reflect on is **“judging future value based on past glory”**. When the stock price fell from HKD 185 to HKD 94, we need to reflect whether the “myth of high growth in China’s e-commerce” that supported its stock price has burst? Today, Alibaba faces not only competition, but also the peak of the entire internet industry’s growth dividend. **A P/B of 1.69x is likely a value trap, not a value trough.** If the Bullish Analyst’s logic holds, then we should buy every company whose stock price has halved, which is obviously absurd. **Summary of my bearish stance:** 1. **Fundamentals deteriorating**: Profits down 20%, revenue nearly stagnant – this is not a short-term pain but structural deceleration. 2. **Technical trend bearish confirmed**: Moving averages in bearish alignment, rebounds on low volume, declines on high volume – downtrend far from over. 3. **Valuation trap**: A low P/B is a reasonable reflection of declining profitability, not a market mispricing. With a P/E of 19.83x, there is no margin of safety amid profit decline. 4. **Lack of catalysts**: Market sentiment neutral, no new story, stock lacks upward momentum. The risk of investing in Alibaba (09988) does not come from “possibly missing a rebound”, but from “catching a falling knife in a downtrend and suffering permanent loss of principal”. Rather than believing in a beautiful “valuation repair” fairy tale, it is better to face the present bearish technical chart and the declining profit statement. The market’s wisdom often lies in those prices that “look very cheap”.

research_team_decision

Alright, everyone. After a thorough review of the debate on Alibaba (09988), I must now give a clear and actionable decision: **Sell**. This decision is not easy, especially when a company's stock price has already been cut in half and the P/B ratio appears to be only 1.69x. But looking back at my past mistakes, the most expensive lesson was 'thinking it was cheap because the stock had fallen a lot, then buying too early, only to fall into a value trap.' This time, I cannot let the same mistake happen again. Next, I will strictly follow the symmetric decision criteria and explain step by step why I reject Buy, why I reject Hold, and why I ultimately choose Sell. --- ### ❌ Why Not Buy? The core of a bull analyst is 'low valuation' and 'oversold bounce.' But these arguments, in the face of current evidence, do not convince me. First, his so-called 'margin of safety'—**P/B of 1.69x**—is not a signal of undervaluation amid a profit collapse, but rather **the market's rational pricing of earnings power deterioration**. Fundamentals show that Alibaba's net profit fell 20.38% year-over-year, while revenue growth was almost stagnant at only 2.74%. Behind the low P/B ratio is an ROE of only 9.91%, a return that does not provide strong impetus for value revaluation. If profits continue to decline, book value per share may also be eroded, turning the 1.69x P/B into a moving target with no real margin of safety. Second, the 'oversold' calls on the technical side ignore the power of the trend. The RSI of 29.69 is indeed in oversold territory, but the stock price is clearly below the MA10, MA20, and MA60—a textbook **bearish alignment**. The most critical factor is trading volume: heavy volume on declines (141 million and 176 million shares on June 25 and 26, respectively) and sharp contraction on bounces (only 67 million shares on July 3). This is not exhaustion of sellers, but rather the bulls have failed to organize an effective counterattack. Trying to catch a bounce in such a trend is like catching a falling knife, with extremely high risk. Finally, the market lacks any catalysts. News analysis shows an information vacuum and neutral sentiment. No new stories, no policy tailwinds, no earnings surprises—what will drive the stock price? Faith in 'valuation repair' is not enough; real buying capital must come in. And right now, buying interest is clearly insufficient. Therefore, the evidence for buying is completely insufficient to outweigh the bearish evidence. I cannot recommend buying based solely on 'looking cheap.' --- ### ❌ Why Not Hold? Holding implies that the bull and bear arguments are evenly matched, but what I see is a clear imbalance. The bear side provides specific and mutually reinforcing evidence: structural profit decline, stagnant revenue, a confirmed bearish technical trend with weak bounces. These facts form a clear logical chain—fundamental deterioration is driving the stock price down, and the technicals fully align with this trend. In contrast, the bull side's arguments are mainly 'low valuation' and 'oversold conditions could brew a bounce,' but these are vague possibilities lacking concrete catalyst support, and they appear fragile when countered by the bear analyst's data. If I were to say 'both sides have merit' and choose to hold, I would be abandoning my responsibility as a portfolio manager to exercise judgment. The current situation is not a mixed signal that is difficult to analyze; rather, the downside risk is clear and pressing. Therefore, holding does not meet the strict standard of 'bull and bear exactly offsetting,' and it must be rejected. --- ### ✅ Why Sell? The evidence for selling overwhelmingly outweighs the bullish arguments. The following three points are the foundation of my decision: 1. **Fundamental deterioration is a structural issue, not a temporary pain point**. Net profit down 20.38% and revenue nearly stagnant—these two data points cannot be fully explained by 'increased strategic investment.' They reflect Alibaba's continuous loss of market share in core e-commerce to Pinduoduo and Douyin E-commerce, while macro consumer weakness further suppresses growth. For a trillion-revenue giant, if the growth engine stalls, the market will quickly shift from 'growth stock valuation' to 'value stock or even declining stock valuation.' The current P/E of 19.83x is based on past earnings that have not yet fully reflected the downward trend, offering no safety cushion. 2. **Technical indicators send a clear signal of continued downside**. The bearish alignment of moving averages, the volume pattern of heavy selling on declines and light volume on bounces, all indicate institutional money is exiting while retail investors try to buy the dip but cannot reverse the tide. RSI oversold can persist for a long time in a strong trend; this is not a reason to buy, but a warning not to go against the trend. The stock price still has room to the lower Bollinger Band of HK$84.75, and the recent low of HK$88.65 is likely not the bottom. 3. **Lack of any visible short- or medium-term catalysts**. Information vacuum, neutral sentiment, no major news—this indicates the market is indifferent to this stock, and new capital will not rush in. In such a situation, the only direction for the stock price is along the path of least resistance, and currently that path is downward. Taken together, the risks of continuing to hold or buy far outweigh the opportunities. Selling is the clearest decision based on the available evidence. --- ## 📊 Investment Plan and Target Price Analysis ### 🎯 My Recommendation: Sell Alibaba (09988) **Rationale**: Fundamental profit decline and technical bearish trend are resonating. Valuation appears cheap but is actually a reasonable reflection of earnings deterioration, and there is a complete lack of catalysts to reverse the downturn in the short term. The downtrend is clear, and holders face the risk of further capital loss. ### 📈 Strategic Actions - **For existing shareholders**: It is recommended to start reducing positions during any small bounces (e.g., when struggling toward the HK$96-98 area), and do not hesitate. If the stock price directly breaks below the recent low of HK$88.65, execute a stop-loss decisively and pull out capital. - **For those with no position or looking to short**: You may establish a short position near HK$94, with an initial stop-loss set above HK$98 (i.e., above the MA10 resistance area in the bearish alignment). The target is the technical support level below. - **Risk management**: Strictly control position size, and do not relax stop-loss just because 'the stock has already fallen a lot.' Remember my lesson—**Never assume there is no further downside just because the price has dropped.** ### 💰 Target Price Analysis (Based on Data in the Report) I will extract key price levels from the report to construct three scenarios: conservative, base, and optimistic. But please note, our decision is to sell, so the focus is on the reasonableness of the downside targets. - **Conservative Scenario (Sell Target, 1 Month)**: **HK$84.75**. This is the lower Bollinger Band given in the technical analysis report, and also the most direct support after the recent heavy-volume decline. Given the bearish momentum, the probability of reaching this level within one month is high. - **Base Scenario (3-Month Target)**: **HK$83.50 – HK$85.00**. The conservative P/B valuation in the fundamental report is 1.5x, corresponding to a stock price of approximately HK$83.5 (BPS 55.64 × 1.5). If the market further prices in profit decline, this would be a reasonable value regression level. At the same time, this range overlaps with the lower Bollinger Band, forming dual technical and valuation support. - **Optimistic Scenario (6-Month Slowdown in Decline)**: **HK$80.00**. This figure comes from the 'stop-loss level' reference in the fundamental report—if it breaks below HK$80, a reassessment is warranted. I take it as a risk-adjusted target under extreme pessimistic sentiment. If future earnings reports show continued profit decline, the 1.69x P/B cannot hold, and the stock price may find a bottom here. Timeframe and Specific Targets: - **1-Month Target Price: HK$84.75** (Lower Bollinger Band) - **3-Month Target Price: HK$83.50** (Conservative P/B Valuation) - **6-Month Target Price: HK$80.00** (Risk-Adjusted Extreme Value) Please don't misunderstand—I am not saying Alibaba will go bankrupt. It remains a giant with strong cash flow and a solid balance sheet. But as traders, we trade the future direction of the stock price, not the survival of the company. Given all available evidence, the path downward is clearer and more likely than the path upward. Therefore, selling is the most reasonable action at this moment.

risky_analyst

Risky Analyst: I understand your position, but here I must play the role of an aggressive risk analyst, challenging the existing framework. Your "Sell" recommendation, frankly, is a conservative product held hostage by fear and short-term data. What I see is a severely undervalued treasure, while you only see the surface dust. Let's break down your arguments directly: **1. On "Structural Fundamentals Deterioration" and "Profit Decline of 20%"** You are fixated on the -20.38% net profit growth, as if this were Alibaba's death sentence. But this is a classic "missing the forest for the trees" fallacy. The report clearly points out that revenue **is still growing** (+2.74%), with annual revenue exceeding HKD 1 trillion. The reason for the profit decline is not explicitly stated in the report, but it is a common phenomenon during cyclical adjustments or strategic investment periods (e.g., massive spending on cloud computing, AI). The market has fully priced in this pessimism — the stock price has plunged nearly 50% from its 52-week high of HKD 184.57, and the RSI has dropped to an extreme oversold level of 29.69. This is not a warning signal of fundamental deterioration, but rather **an excellent buying opportunity due to excessive market sentiment reaction**. Your view misses the key question: **When bad news is fully priced in, what is the next catalyst?** That is the source of high returns. What you call a "value trap" is precisely our golden pit for contrarian positioning. **2. On "Technical Bearish Arrangement" and "Shrinking Volume on Bounce"** You emphasize the bearish arrangement of MA60 > MA20 > MA10, which is true. But the true art of technical analysis lies in interpreting **signs before the turning point**. The report clearly states: "The MACD negative value slightly narrowed, suggesting that downward momentum may be weakening." This is like the eye of a typhoon — the calmest moment often heralds a reversal. The RSI at 29.69 in oversold territory may persist in a strong trend, but when it coincides with a stock price that has halved from its high and is near **multiple technical supports** at the 52-week low (88.65) and the lower Bollinger Band (84.75), this is not mere oversold but **an extreme betting point under extreme pessimism**. What you call "shrinking volume on bounce" is a classic bottom characteristic — retail investors are fearful, afraid to chase, and chips are shifting from weak hands to strong hands (e.g., company buybacks or smart money). After a volume-driven decline, a low-volume bounce precisely indicates that panic selling has been cleared and selling pressure is exhausted. This is not a reason to open a short position, but a signal to establish long positions on dips. **3. On "Lack of Short-term Catalysts" and "Neutral Sentiment"** You see a news vacuum as a bearish signal, but I see it as **a perfect quiet accumulation period for the market**. The sentiment report shows "Neutral (Score 0.00)", meaning the market is neither euphoric nor desperate — extremely calm. In financial markets, calm is often a prelude to a storm (whether bullish or bearish). When everyone is as cautious and waiting as you are, this trade has lost its crowding. True excess returns come from **contrarian positioning before market consensus forms**. The company holds strong cash flow, and its valuation (P/B 1.69x) is at an absolute historical low — this itself is the strongest endogenous catalyst. Waiting for earnings or policy surprises to chase will leave only bones, no meat. **4. On "Valuation Trap Risk" and "Margin of Safety"** You mention that a P/B of 1.69x seems cheap, but ROE is only 9.91%. This is a classic but potentially misleading argument. You ignore the assets' **replacement cost** and **future earning power**. Alibaba's assets include strategic assets like the Taobao & Tmall ecosystem, Alibaba Cloud, and Cainiao Logistics, which are difficult to replicate. A P/B of 1.69x means the market is discounting these massive assets. Your Sell target of HKD 84.75 corresponds to a P/B of about 1.52x (84.75/55.64). If a trillion-dollar tech giant's book net assets have a nearly 50% discount, that is not an insufficient margin of safety, but **an absurd mispricing**. **My Contradictory Conclusion and High-Return Action Recommendation:** Your cautious logic assumes the worst-case scenario will happen. My aggressive logic is: **Extreme pessimism is already priced in; the market is standing at a point of extremely asymmetric risk-reward**. Downside is limited (technical support at HKD 85-88, about 6-10%), but potential upside is huge (valuation recovery to neutral range of HKD 100-110, i.e., 15-20%; if sentiment reverses, it could surge to above HKD 120, returning over 30%). **Therefore, I challenge your Sell recommendation and propose the opposite operation:** This is a textbook **high-risk, high-reward contrarian trade**. The best risk management is not to stop loss and exit, but to **build positions in batches when severely undervalued**. Use the market's irrational selling to create excess returns. If you liquidate now, you will forego a potential 50% or even higher future upside, just to avoid a possible short-term downside risk of maybe 10%. Is that not the worst risk management? I believe selling is actually the high-risk strategy, because it exposes you to the opportunity loss of missing a major valuation recovery. Embrace risk; opportunity always arises when fear prevails. Risky Analyst: Okay, I have carefully listened to both of your closing statements. Safety Analyst, your caution is like a thick city wall, providing shelter for funds, but it also traps you forever inside the city, missing the vast territory outside. Neutral Analyst, you try to find a flat path between the city wall and the wilderness, but this path will only prevent you from enjoying the absolute safety inside the city and from truly reaching the treasure. Your arguments, in my view, both fall into the same mental trap: **equating "uncertainty" with "risk", thereby missing the excess return opportunities brought by "uncertainty".** I will stand high, overlook the entire chessboard, and point out the ultimate and fatal blind spot in your logic. ### Directly Refuting the Safety Analyst: You Ignore the Immense Risk of "Inaction" The core of your entire thesis is "permanent loss of principal," and you dismiss my view as a "bottom-fishing" trap. This is your most fundamental error. **Permanent loss of principal comes not only from price decline but also from long-term erosion of purchasing power and permanent loss of opportunity cost.** 1. **On the doubt that "profit decline is strategic investment"**: You accuse me of "subjective assumption," but you are also making subjective assumptions. You assume that the profit decline is a permanent state of "core business market share erosion" and "margin compression." **The report has no evidence to support your assumption, nor does it have evidence to support mine.** But the key difference is: **The market has fully priced in your pessimistic assumption — the stock price plunge of 50% is proof. While my optimistic assumption — that this is cyclical or strategic adjustment — once confirmed, will bring massive valuation recovery.** You bet that bad news will continue; I bet that bad news is already priced in, and marginal improvement will create huge returns. Your bet is based on the continuation of the status quo; my bet is based on the timeless market law of mean reversion. Which is more rational? 2. **On "Falling Knife" and "Dead Cat Bounce"**: You interpret "MACD negative narrowing" and "RSI oversold" as dangerous signals. But what does the report mean by "downward momentum may be weakening"? **It means the force driving the stock price down has exhausted.** When selling power is exhausted and the stock is severely undervalued, any small buying can trigger a strong bounce. The so-called "falling knife" you mention is losing its momentum, yet you refuse to reach out for fear of being cut. This is not risk management; it is irrationality held hostage by fear. Every bottom in history forms in such despair of "bounce with shrinking volume, weakening momentum." 3. **On "Low Valuation Is Not a Catalyst"**: You are absolutely right: low valuation itself is not an immediate catalyst to rise. But it is **risk compensation**. If you sell and hold cash, what is the return on cash? Close to zero. Meanwhile, my position has a P/B of 1.69x, meaning I own a trillion-dollar tech giant at close to net asset value. **Even if the stock price does not rise in the short term, the price I hold is cheap enough, which itself is a kind of protection.** The "value trap" risk you mention only occurs when profits continuously and permanently deteriorate. But the report clearly states that the company's financial position is **healthy**, with a debt ratio of 41%, a current ratio of 1.28, and revenue still growing. How can you be sure this is a trap that will never rebound? Your argument is built on fear of the most extreme, least likely scenario. ### Directly Refuting the Neutral Analyst: Your Balanced Plan Is Inherently Self-Contradictory Your proposal sounds reasonable, full of balanced wisdom. But in my view, it is a logically inconsistent compromise that will ultimately leave you empty on both sides. 1. **The Fallacy of "Halving the Position, Keeping Half"**: The core assumption of this strategy is "we don't know where the market will go," so you bet equally. But this precisely avoids the core of decision-making: **Is the current risk-reward ratio favorable?** If the current risk-reward is extremely favorable (downside 10%, upside over 30%), then any reduction is lowering the potential huge gain in exchange for a non-existent "certainty." The half you sell is precisely the most profitable portion of the future rebound. You sacrifice huge upside potential for a little volatility protection. 2. **Your Action Trigger: The Paradox of Waiting for Certainty**: Your signal to add positions is "the stock price closes above the 10-day moving average for two consecutive days" and "MACD turns positive." When these signals appear, the stock price may have already risen 15-20% from the bottom. At that point, you will face a tougher choice: buy back at a high or give up? If you chase, your cost will be much higher, and the risk-reward will be far worse than entering now. If you give up, you will forever miss the juiciest first leg of the rally. **What you call "following the trend" is actually chasing information already reflected in price — a mediocre strategy that lags the market.** True excess returns come from early positioning based on deep understanding of valuation and extreme sentiment, before market consensus forms and before signals are clear. 3. **Your Watchlist Is Self-Deceptive**: You have set a clear exit point (break below HKD 88.65). This seems to control risk. But think: if the stock price really breaks below HKD 88.65, market sentiment will be even more panicked than now, MACD may deteriorate further, and negative news (not provided in the report but could appear anytime) will flood. Will you really be able to execute a stop loss rationally then? Or will you hold on because of greater fear? **Your strategy essentially uses a "seemingly rational framework" to mask your inner uncertainty and fear.** It does not solve the fundamental problem: you dare not place a heavy bet when valuations are extremely low and sentiment is extremely pessimistic. ### My Final Conclusion and Call to Action Both of you are trying to avoid "uncertainty" with "smaller, more controllable risks." But you fail to realize that **at times of extreme undervaluation, the biggest risk is not price decline, but missing the opportunity.** Safety Analyst, the safety you provide is static safety, the safety of being poor. Neutral Analyst, the balance you provide is mediocre balance, the balance that is destined not to achieve excess returns. I stand by my high-return action recommendation: **Do not sell, and do not reduce positions. Now is the time for contrarian accumulation.** Use the market's extreme pessimism to buy a dominant tech giant with monopoly status, strong cash flow, and trillion-dollar revenue at a price close to net asset value per share. The downside risk of this trade is limited by extreme pessimistic valuation, while the upside is determined by the extent of market sentiment repair and the speed of fundamental improvement. This trade has extremely asymmetric risk-reward. **Assuming current volatility risk is to exchange for huge certain future returns.** Your caution and balance, frankly, are a lack of confidence in your own judgment — handing decision-making over to the short-term emotions of the market. True risk management is not fleeing in fear, but staying calm in panic, and daring to build your long positions when consensus collapses. **Embrace risk, because at this moment, it is the only path to excess returns.** The current decision should not be to sell, but to bravely stand on the side of the minority.

safe_analyst

Safe Analyst: Okay, I have received your instructions. As a safe/conservative risk analyst, I have thoroughly reviewed the trader's decisions and the aggressive analyst's views. My responsibility is to protect company assets and minimize volatility, so I will strictly adhere to risk management principles and provide a critical review. Before diving into the risks, I must acknowledge that there are indeed positive factors in the company's fundamentals report. Revenue continues to grow positively (+2.74%), reaching an annual revenue scale exceeding 1 trillion HKD, and the gross margin is stable at 39.81%, indicating that its core business still has strong cash flow generation capabilities and market leadership. These are the cornerstones of its long-term value, which I fully recognize. However, regarding the trader's proposal of a 「Sell」, I **fully support** it. This decision perfectly embodies the core spirit of us as safe/conservative risk analysts: **between potential long-term returns and clear short-term risks, unconditionally choose the latter to ensure asset safety**. Next, I will refute the aggressive analyst's optimistic arguments one by one and point out the hidden risks in his approach that could cause significant losses to the company's assets. **Regarding the aggressive analyst's 「severely underestimated treasure」 view:** The aggressive analyst interprets the stock price halving and profit decline as a "excellent buying point due to excessive market sentiment reaction," which is precisely the 「bottom-fishing mindset」 trap we must avoid. He defines risk as 「missing opportunities,」 but for us, the real risk is **permanent loss of principal**. 1. **Regarding 「revenue still growing positively」 and 「profit decline is strategic investment」:** Yes, revenue is growing, but **only 2.74%**, which cannot support a reasonable valuation multiple, let alone cover the net profit decline of **as much as 20.38%**. We must not subjectively assume that the profit decline is a "strategic investment"; the report provides no evidence to support this. A more reasonable interpretation is that core business market share is being eroded and margin compression due to macro consumption weakness. Without clear evidence of profit stabilization and recovery, any talk of "strategic investment" is mere speculation. We cannot gamble company funds on a guess. 2. **Regarding 「technical reversal signals」 and 「extreme betting point under extreme pessimism」:** The report clearly states that the MACD negative value has "**narrowed slightly**," not a "golden cross" or reversal signal. RSI at 29.69 is in the oversold zone, but the report also emphasizes that "**in a strong downtrend, RSI may linger in the oversold zone**." Interpreting 「weakening downward momentum」 as an imminent reversal is extremely dangerous. This is not a "eye of the storm," but a "**falling knife**." Trying to catch a falling knife in a strong bearish trend is the most common cause of huge losses. The pattern of 「declining on volume, bouncing on low volume」 mentioned by the trader does not necessarily prove that shares are transferring from retail to capable and patient institutions? Not entirely correct. It is more likely to indicate that **the market lacks new buying power to support the price**, and any rebound may just be a temporary "dead cat bounce." 3. **Regarding 「lack of short-term catalysts is a period of accumulation」 and 「PB 1.69x is an absurd mispricing」:** This point best illustrates the fundamental difference between the aggressive analyst and us. For a trillion-dollar giant in fierce competition (Pinduoduo, Douyin) with an uncertain macro environment, **low valuation itself is not a catalyst**. Catalysts are specific events that drive profit growth, such as earnings beats, new business breakthroughs, or policy tailwinds. Before these clear signals emerge, a quiet period is a risk period because the stock price will move along the path of least resistance (downward). His mention of "asset replacement cost" is ineffective for a troubled company. When profits continue to decline, the ability of these assets to **generate cash flow** diminishes, and their liquidation value may be far below book value. A PB of 1.69x may seem cheap, but what if future profit declines cause book value per share (BPS) to shrink further from 55.64 HKD? Then a 1.69x PB could correspond to an even lower absolute price. This is exactly the "**value trap**" pointed out by the trader. **Benchmark Comparison and Conclusion:** The decision of our current trader has a clear chain of evidence and rigorous logic, fully based on verifiable data from the report (net profit decline of 20%, revenue stagnation of 2.74%, bearish technical arrangement, low volume bounces). He set a clear target price (84.75-80 HKD) and strict risk control, which is professional asset protection. In contrast, the aggressive analyst's recommendation is built on **a series of unsubstantiated assumptions**: profit decline is strategic investment, technology is about to reverse, low valuation is a reason to buy. His so-called "high returns" require us to bear the risk of "stock price possibly falling another 10-14%" in exchange for an **uncertain gain** of "possible future upside of 15-20%". Such a risk-reward ratio is completely unacceptable for our company's assets. Our responsibility is to ensure stable, reliable growth, not to gamble on extreme bets. Therefore, **I strongly support the Sell decision**. In the current environment of high uncertainty and overwhelming bearish evidence, exiting the market and holding cash is the safest and most rational risk management. Waiting for a substantive improvement in the company's fundamentals, or for the price to digest all pessimism and form a clear bottom pattern before considering entry, is a robust strategy aligned with our long-term goals. Embracing risk now might mean embracing a huge loss. Safe Analyst: Okay, as your designated safe/conservative risk analyst, I have carefully reviewed all materials and arguments from all parties. My primary task is only one: protect company assets, ensure stable and reliable growth, and maximize risk avoidance. Before deep-diving into the risks, I must first admit that there are indeed some positive cornerstones in the fundamentals report. Revenue still maintains positive growth (+2.74%), annual revenue exceeds 1 trillion HKD, indicating that its massive scale still has monetization ability. Gross margin is stable at 39.81%, representing that its core business model still has a certain moat. These are the pillars of the company's long-term value, and I fully recognize them. However, regarding the trader's 「Sell」 recommendation, I hereby give **unreserved, strongest support**. This decision is based on solid data and rigorous logic, perfectly embodying our responsibility as risk gatekeepers. Next, I will refute the views of both the aggressive and neutral analysts one by one, and point out the blind spots in their arguments that pose a direct threat to the safety of company assets. **Regarding the aggressive analyst's 「excellent buying point」 and 「contrarian adding positions」 arguments:** The aggressive analyst defines risk as "missing opportunities," which is an extremely dangerous mindset for us. Our responsibility is to avoid "permanent loss of principal," not to chase hypothetical excess returns. 1. **Regarding the fatal assumption that 「profit decline is strategic investment」**: This is the cornerstone of your entire optimistic forecast, but it **has absolutely no data support in the existing report**. The report clearly states that net profit declined 20.38% year-over-year, but provides no evidence that the disappeared profits were invested into future growth areas such as "cloud computing or AI." Your statement is merely an unsubstantiated "nice story." We cannot use company funds to bet on a story. A more reasonable interpretation is that this reflects direct erosion of core profitability due to macro consumption weakness and increased competition. Until the report provides any evidence of profit stabilization and recovery, we must assume the decline will continue; this is the basic discipline of asset protection. 2. **Regarding the misinterpretation of 「MACD negative value narrowing as momentum exhaustion」**: The report states "MACD negative value **narrowed slightly**," not "impending golden cross" or "trend reversal." This is like the brief calm at the center of a typhoon; it does not mean the typhoon has passed. In a strong bearish trend, this "slight narrowing" signal is extremely fragile and can be destroyed at any moment by a new wave of selling. Your interpretation as "momentum exhaustion" is looking for a non-existent bottom signal, which is typical behavior of "catching a falling knife," historically causing huge losses. The pattern of "declining on volume, bouncing on low volume" highlighted in the trader's report precisely indicates a lack of sustained buying power, a bearish-dominated pattern, not a bottom characteristic. 3. **Regarding the logical fallacy of 「low valuation is not a catalyst, but risk compensation」**: You are right that low valuation itself is not a catalyst for an upswing. But you overlook a key point: **when profits are persistently declining, low valuation is an extremely dangerous trap**. You mention PB 1.69x, but if future profits continue to fall, what happens to book value per share (BPS)? It shrinks. At that point, a 1.69x PB could correspond to an even lower absolute stock price. This is exactly the "**value trap**" the trader mentioned—you think you are buying a bargain, but in reality you are buying a depreciating asset. Your so-called "risk compensation," in the face of profit decline, is just an illusionary safety net. Our duty is to avoid traps, not to jump in and gamble they won't collapse. **Regarding the neutral analyst's "reduce half, keep half" balanced approach:** Your approach seems rational and moderate, but in my view, it can neither effectively control downside risk nor truly capture upside opportunities; it is inherently self-contradictory. 1. **Regarding the logical dilemma of "reduce half"**: Your approach assumes "we don't know where the market will go." But what we do know is that the current risk-reward ratio is extremely unfavorable. The trader has clearly pointed out that the stock price has a clear downside of 9-14% from the current level (to 84.75-80 HKD), while any upside lacks clear catalysts. In this situation, keeping half a position means we actively take on 50% of a clear, quantifiable downside risk. At the same time, the half you sell incurs the opportunity cost of "completely missing the rebound." This is a lose-lose structure. True risk management is not splitting the bet between risk and opportunity, but **when risk far outweighs opportunity, choosing to exit**. 2. **Regarding the fatal delay of "wait for reversal signal then add positions"**: Your add position signal is "stand firmly above the 10-day moving average for two consecutive days and MACD turns positive." That sounds reasonable, but the cost is huge. By the time these signals appear, the stock price may have already rebounded 15-20% from the bottom. Then we face a more painful choice: chase and buy back a stock that has already risen 20%, or watch it continue to rise and miss out? Your strategy is essentially "sell low, buy high." A truly robust strategy is **to enter the market after prices have digested pessimism and formed a clear bottom pattern, under controllable risk**, not to use "reduce half" as a pretense for risk management during a downtrend. **Final Verdict and Action Recommendation:** The aggressive analyst's recommendation is based on an unsubstantiated "strategic investment" story and mistakes market irrational pessimism for an opportunity; it is highly speculative. The neutral analyst's recommendation is an apparently balanced but self-defeating strategy; it can neither protect assets at critical moments nor effectively seize opportunities when they arise. The decision of our current trader has a clear and complete chain of evidence: **profit decline (-20.38%), revenue stagnation (+2.74%), bearish technical arrangement, low volume bounces indicating lack of buying, valuation in a trap range**. Each of his conclusions is based on verifiable data from the report, and he has set clear target prices and risk management discipline. Therefore, I **strongly support the Sell decision**. In the face of current uncertainty and overwhelming bearish evidence, **stepping aside to observe and holding cash is the best risk management we can do**. We should not gamble a "certain" downtrend for a "possible" valuation repair. Only after the company's fundamentals show substantive, verifiable improvement, or after the price has completed a bottoming process at a sufficiently low level and clear reversal signals emerge, should we consider re-entering the market. Embracing risk now will only embrace losses. Protecting assets is our unwavering highest principle.

neutral_analyst

Neutral Analyst: OK, as a neutral risk analyst, I have carefully listened to both the aggressive analyst and the safety analyst's perspectives. I must say, you both have grasped part of the truth, but each of you has gone too far in your own logic. One sees a treasure that is undervalued but ignores the bleeding knife right in front; the other sees the sharpness of the knife and therefore dares not approach the treasure gate. Let me show you how to take that balanced path. First, I want to directly point out the most fragile core of the aggressive analyst's argument: **"The profit decline is a strategic investment."** This assumption is the foundation of all optimistic forecasts, but it is **completely unsupported by any data** in the existing reports. The fundamentals report clearly shows net profit down 20.38% year-over-year, with revenue growth of only 2.74%. You can call this a "cyclical adjustment" or "market overreaction," but you cannot simply assume it is an investment that will yield future returns. There is no evidence that these funds flowed into cloud computing or AI and will generate returns next quarter. This is not contrarian investing; this is gambling. Your entire high-return thesis is built on an unproven beautiful story, which poses too much risk to the company's assets. However, I must also challenge the safety analyst's view. You fully support selling and interpret all negative signals as doomsday. You argue that "revenue growth of only 2.74% cannot support the valuation" — I agree on that point. But you also overlook a key positive signal in the fundamentals report: that report explicitly states that the current P/B ratio (1.69x) is at a historical low and judges that "Alibaba's current stock price is in an undervalued range." It's the same official report — you selectively believe its warning about profit decline but completely deny its judgment of "significant undervaluation." You say "low valuation itself is not a catalyst," and that's true. But low valuation provides a margin of safety — a cushion that protects you from serious injury when you are wrong. If we completely liquidate now, and the stock price indeed starts its valuation recovery from the "bottom area" as the fundamentals report suggests, we would suffer a huge opportunity cost. Your strategy is not risk management; it is risk avoidance that fully exposes us to the risk of missing the rebound. So, my balanced plan is very clear: **Don't sell everything, don't buy everything. We will adopt a conditional, phased reduction strategy and set up a watchlist.** **My specific recommendation is: Partially reduce positions, free up cash, but retain a core position as a "strategic call option."** **First, why reduce?** The safety analyst's core concern is correct — bearish technical arrangement, "declining volume on down moves, rising volume on up moves," and profit decline are objective facts. Until these signals reverse, the risk of the stock price moving along the path of least resistance (downward) is real. We cannot hold on to a "possible" valuation recovery and endure a "certain" downtrend. Therefore, I recommend **reducing our Alibaba position by half**. This is not surrender; it is to keep the hull intact during the storm. The cash obtained from selling this portion becomes ammunition to buy at lower levels (e.g., near the Bollinger Band lower rail at 84.75 HKD) and a buffer to safely weather volatility. This fully aligns with the safety analyst's core principle of capital preservation. **Second, why retain a position?** Because the "absurd mispricing" mentioned by the aggressive analyst does exist. A P/B valuation of 1.69x for a company with annual revenue exceeding 1 trillion HKD is a historically rare low. The fundamentals report also endorses this. If we sell everything and the stock price does rebound due to some catalyst (even if we don't see it now), we would have to buy back at higher prices or miss out forever. Retaining half of the position allows us to participate in potential valuation recovery while keeping downside risk within an acceptable range. This embraces opportunity while managing risk. **Third, when to act?** We cannot wait indefinitely. We need to set **a clear watchlist and action triggers.** 1. **Bullish reversal signal (add position trigger)**: When the stock price **closes above the 10-day moving average (96.51 HKD) for two consecutive days** and the MACD histogram **narrows significantly and turns positive**, only then is the "reversal sign" that the aggressive analyst speaks of confirmed. At that point, we can use the cash from the reduction to add back positions and follow the trend. 2. **Bearish downside signal (reduce or exit trigger)**: If the stock price **effectively breaks below the recent low of 88.65 HKD**, the next technical support would directly target the Bollinger Band lower rail at 84.75 HKD, or even lower. At that point, to avoid the "falling knife" the safety analyst warns about, we should also stop-loss the remaining half of the position and exit completely. This is not predicting the bottom; this is respecting the market's choice. In summary, aggressive analyst, your vision is too forward-looking and you ignore the cliff at your feet; safety analyst, your focus is too fixed on the cliff and you fail to see the path beside it. My suggestion: **Don't be an extreme gambler, nor a cowardly deserter. Be a disciplined soldier with a plan.** Reduce half, retain half, and use this flexibility to deal with any market possibility. That is the truly robust and sustainable balanced approach. Neutral Analyst: OK, I have listened to both sides' closing arguments. I must say, this debate is brilliant, but precisely because of that, you both have each boxed yourselves into a corner. Aggressive analyst, you see the treasure but refuse to acknowledge that the city gate may be surrounded by traps; safety analyst, you see the traps and would rather give up the entire city. You are both convincing yourselves with self-consistent logic, but you ignore the most critical variable in the real world: **uncertainty itself.** Let me directly point out the most fatal flaw in both of your arguments. **To the aggressive analyst: Your assumption of "certainty" is the most uncertain thing.** Your core argument rests on a strong belief: "bad news is fully priced in." You think the 50% stock price plunge is proof. But that is the weakest link in your logic chain. **Price reflects known pessimistic expectations, but the market can never price "unknown unknowns."** How can you be certain that a 20.38% profit decline is the bottom? What if the next quarterly report shows another 25% decline? What if macroeconomic consumption data continues to deteriorate? What if competitors (Pinduoduo, Douyin) further erode market share? These are not extreme scenarios that are "impossible." Your so-called "mean reversion" is a statistical long-term regularity, but for a single stock at a specific point in time, it may never happen, or it may take a very long time. The volatility risk you take could easily become permanent principal loss. You ignore the safety analyst's core concern: **In the absence of clear evidence, assuming that profit decline will persist is a more robust risk management discipline than assuming it will reverse.** **To the safety analyst: Your "risk-avoidance" strategy itself creates new risks.** Your argument is impeccable and logically rigorous, but precisely because of that, it exposes the limitations of "pure risk avoidance" in investment practice. You completely lock in downside risk, but you also lock out all upside potential. You tell me to "hold cash," but in an inflationary environment, the real purchasing power of cash is being eroded — isn't that a certain permanent loss? More importantly, you completely ignore the key judgment in the fundamentals report: "Alibaba's current stock price is in an undervalued range." This is an objective conclusion based on data (P/B at historical low, revenue still growing), not a "subjective assumption" as you call it. You selectively ignore it. If we liquidate now, and the stock price indeed experiences valuation recovery to the neutral range (e.g., 95-110 HKD) within the next six months as the fundamentals report suggests, we would suffer a huge opportunity cost. **Your strategy essentially uses a quantifiable opportunity cost to avoid an unquantifiable downside risk that may not materialize. That is not optimal risk management; it is over-defense.** **Therefore, my balanced plan is: Don't buy all, don't sell all, but sell to create a conditional, asymmetric structure.** Specifically, I disagree with the aggressive analyst's "contrarian adding" and the safety analyst's "full selling." My recommendation is: **Partially reduce positions, and use the proceeds to build a strategy that combines a "protective put option" and a "watchlist."** **Step one: Why partially reduce?** Because the safety analyst's observation of the bearish technical arrangement and "declining volume on down moves, rising volume on up moves" is objective. Until a clear reversal signal appears, the risk of the stock price moving along the path of least resistance (downward) is real. Reducing half the position frees up cash, lowers our risk exposure, and avoids unnecessary losses during a confirmed downtrend. This is not surrender; it is preserving strength. **Step two: Why not sell the entire position?** Because the "absurd mispricing" the aggressive analyst mentioned — a P/B of 1.69x — is indeed a clear data point in the report. This provides a sufficiently thick margin of safety. If we completely liquidate and the stock price does begin valuation recovery due to some catalyst (e.g., a better-than-expected buyback announcement, or favorable macro policy), we would be forced to buy back at higher levels or miss it forever. Retaining half the position keeps a "low-cost call option" that allows us to participate in potential valuation recovery. **Step three: Core action — establish an actionable watchlist and trigger points.** We cannot wait indefinitely. I recommend setting **a clear watchlist based on report data:** 1. **Bullish reversal signal (add position trigger)**: When the stock price **closes above the 10-day moving average (96.51 HKD per report) for three consecutive trading days** and **the MACD histogram turns from negative to positive (i.e., forms a golden cross)**. This is the signal that the "momentum exhaustion" the aggressive analyst spoke of is confirmed by the market. At that point, we can use the cash from the reduction along with our retained position to add positions in line with the trend. 2. **Bearish confirmation signal (reduce or exit trigger)**: If the stock price **effectively breaks below the recent low of 88.65 HKD mentioned in the report**, then the next technical support directly targets the Bollinger Band lower rail at 84.75 HKD. At that point, to avoid the "falling knife" the safety analyst worries about, we should stop-loss the remaining half of the position without hesitation and exit completely. This is not predicting the bottom; it is respecting the market's choice. 3. **Neutral waiting signal (maintain current position)**: If the stock price oscillates between 88.65 HKD and 96.51 HKD, and the MACD remains in negative territory, then we maintain the status quo of "half reduced" — neither adding nor reducing, patiently waiting for the market to choose its direction. **In summary, my strategy is not a compromise, but a more refined risk management framework.** Aggressive analyst, you are betting on the beginning of a beautiful story; safety analyst, you are paying upfront for a pessimistic ending. My plan is: **Sell a portion to hedge against the worst case, retain a portion to embrace the best possible outcome, and use a clear watchlist to decide the next move.** That way, no matter which direction the market ultimately chooses, we have a contingency plan and will not be caught off guard. This is true balance — avoiding the harm of extreme volatility while retaining the right to participate in growth.

risk_management_decision

Good, as the Chairman of the Risk Management Committee and the moderator of this debate, I have carefully weighed the intense exchanges among the three analysts and combined the valuable lessons from the Research Manager's past mistakes. My goal is to provide traders with an evidence-based, logically rigorous, and immediately actionable decision. Now, I deliver the final verdict. --- ### 🎯 Final Decision: Sell Alibaba (09988) This decision confirms and supports the Research Manager's initial judgment. After a comprehensive review of the debate, especially the symmetrical rejection of both Buy and Hold options, Sell is the only course of action that aligns with the current weight of evidence and risk management discipline. --- ### ❌ Why Reject Buy? The core argument of the aggressive analyst — 'Extreme pessimism has been priced in, and the market is at a point of extremely asymmetric risk-reward' — sounds appealing, but does not withstand rigorous scrutiny of the evidence. His entire bullish thesis is built on a castle on the sand: **'The profit decline is strategic investment.'** As the safety analyst sharply pointed out, **this assumption has no data support in the existing reports.** The reports show a 20.38% year-over-year decline in net profit, but do not indicate that the funds went into projects that can generate future returns. Attributing the profit plunge to strategic investment is pure speculation, not fact-based analysis. We cannot use the company's funds to endorse an unverified story. Secondly, the 'margin of safety' he relied on — PB of 1.69x — was jointly debunked by the neutral analyst and the safety analyst as a potential **value trap**. The core issue is ROE of only 9.91%. For an asset with a low PB but accompanied by low ROE and declining profits, the low valuation is a rational reflection of the market's deteriorating profitability, not a mispricing. If profits decline further, book value per share will also be eroded, and then the 1.69x PB will correspond to an even lower absolute share price. As the Research Manager learned from his own costly lesson: **'Thinking it's cheap just because the stock has fallen a lot, then buying too early, only to fall into a value trap.'** The aggressive analyst's advice is precisely tempting us to repeat that mistake. Technically, the aggressive analyst interpreted 'MACD negative value slightly narrowing' and 'rally on shrinking volume' as precursors to a reversal, which is an extremely dangerous misreading. In the context of a clear bearish arrangement (stock price below MA10, MA20, MA60) and 'falling on rising volume, rallying on shrinking volume,' a more accurate interpretation of these signals is: **Selling pressure has temporarily eased, but bottom-fishing buying is even scarcer; the market lacks the endogenous momentum to reverse the trend.** This is not the 'eye of the storm,' but a manifestation of waning bullish strength. Buying against the trend without clear technical reversal signals (e.g., consecutive closes above key moving averages, MACD golden cross) is akin to catching a falling knife. Therefore, the case for Buy is built on unverified assumptions and erroneously optimistic interpretations of technical signals, carrying extremely high and uncontrollable risk. I must reject this option. --- ### ❌ Why Reject Hold? The neutral analyst's plan to 'reduce half of the position, keep half' sounds like a rational middle ground at first, but under rigorous symmetrical argumentation, it reveals its strategic flaw—a plan that tries to please both sides but may end up losing on both. The premise for holding or partial holding is that the bullish and bearish arguments are evenly matched, making it impossible to form a directional judgment. However, the current weight of evidence is not so. What we see is a clear and mutually reinforcing bearish logic chain: - **Fundamentals**: Structural profit decline (-20.38%), revenue growth stagnation (+2.74%). - **Technicals**: Stock price in a standard bearish arrangement, rally on shrinking volume indicating insufficient buying. - **Market Sentiment and Catalysts**: Information vacuum, lacking any short- or medium-term catalyst that could reverse the downtrend. In contrast, the bullish arguments are based on vague possibilities such as 'it has already fallen a lot' and 'valuation is very low,' which have been effectively refuted by the safety analyst. In this context of clear and imminent downside risk, retaining half a position means we voluntarily accept 50% of the clear downside risk (stock price sliding towards HK$84.75 or even HK$80) in exchange for a vague and unsupported upside possibility. The neutral analyst's set add-trigger point — 'stock price closes above the 10-day moving average for two consecutive days and MACD turns positive' — precisely confirms the passivity of the hold strategy: By the time those signals appear, the stock price will have already left the bottom, forcing us to chase at a higher cost, effectively achieving 'sell low, buy high.' As the Research Manager said: 'If I now say "both sides have a point" and choose to hold, I am abdicating my responsibility as a portfolio manager to make a judgment. The current situation is not one of mixed signals and difficult analysis, but one where downside risk is clear and urgent.' The neutral analyst's plan essentially postpones the 'responsibility to judge' to the future, while exposing the asset to unnecessary risk in the present. This is not risk management; it is risk procrastination. Therefore, I must reject the Hold option. --- ### ✅ Why Sell? — In Agreement with the Research Manager My risk assessment fully confirms the Research Manager's judgment. The evidence for Sell overwhelmingly outweighs all opposing views. Its foundation has not only been unshaken by counterarguments but has been further solidified in the debate. 1. **Fundamental deterioration is the core driver**: The combination of a 20.38% profit decline and near-stagnant revenue is the root cause of the cascading effects on valuation and technicals. This is not a temporary pain but a dual signal of market share erosion and weak macro environment. The safety analyst's view is decisive: **In the absence of clear evidence that profits have bottomed and rebounded, we must assume the declining trend will continue.** This is a basic discipline to protect assets, not excessive pessimism. 2. **Technicals and fundamentals resonate**: The bearish alignment of moving averages and the volume structure of 'falling on rising volume, rallying on shrinking volume' are a perfect mirror of fundamental deterioration in market trading. These technical signals tell us that smart money is exiting, and retail bottom-fishing cannot gain traction. This is not a consolidation and bottoming pattern, but a continuous process of searching for a floor. 3. **The risk of a 'valuation trap' far outweighs the opportunity for 'valuation recovery'**: This is the most critical risk insight in this discussion. A low PB cannot be a reason to buy, because it reflects the reality of low ROE and profit decline. The principle of 'avoiding value traps' distilled by the Research Manager from his own lessons is our strongest shield against the aggressive analyst's temptation. The safety analyst further pointed out that 'asset replacement cost' is ineffective when profitability is declining, completely dismantling the last bastion of the bullish case. 4. **Lack of catalyst means the path of least resistance is downward**: In a vacuum without positive narratives, policies, or earnings surprises, the only direction for the stock price is to follow the existing bearish trend. Waiting for a catalyst itself is a cost, and the current market tells us that this waiting is likely to be met with further declines. In summary, the reasons to reject both Buy and Hold are clear and overwhelming. Sell is the only rational choice based on all available evidence, risk assessment, and deep reflection on past mistakes. This is not panic; it is discipline. --- ### 📈 Refined Action Plan The trader's original plan is already sufficiently robust. I have only fine-tuned and confirmed it based on the views raised in the debate. - **For existing holders**: Agree to use any small bounces towards the `HK$96-98` zone to begin reducing positions. If the stock price directly breaks below the recent low of `HK$88.65`, must decisively execute a stop-loss without hesitation. This is key to preventing larger losses of the 'boiling frog' variety. - **For those with no positions or who want to short**: Agree to establish a short position near `HK$94`, with a stop-loss above `HK$98`. This is trading in the direction of the bearish trend. The target is clearly aimed at the technical support level below at `HK$84.75`. - **Risk management discipline**: Reiterate the Research Manager's lesson — 'Never assume there is no room to fall just because the price has already fallen.' Low valuation itself is not a reason to buy, especially when profitability is deteriorating. Strictly enforcing stop-losses is the most important lesson we have learned from past mistakes. ### 💰 Target Price Analysis (Confirmed) - **1-month Target Price: HK$84.75** (from the lower Bollinger Band in technical analysis, the most immediate downside target) - **3-month Target Price: HK$83.50** (from conservative PB valuation in fundamental reports, overlapping with the lower Bollinger Band, forming a strong support zone) - **6-month Target Price: HK$80.00** (as a risk-adjusted target under an extreme pessimistic scenario; if profit decline intensifies, PB valuation will contract further) --- ### 🔄 Comparison with the Research Manager's Decision: Confirmation of Consistency My final decision is **fully consistent** with the Research Manager's initial judgment. My risk assessment process systematically examined and confirmed his judgment. This debate did not overturn the sell conclusion; rather, it strengthened it, for the following reasons: 1. **The core risk — 'value trap' — was thoroughly confirmed**: The aggressive analyst not only failed to prove that Alibaba is 'undervalued,' but his argument was dismantled by the safety analyst using data that 'ROE of only 9.91% cannot support low PB appeal.' This directly validates the Research Manager's instinct to avoid repeating past mistakes. 2. **Opposing views lack evidentiary support**: All key optimistic assumptions in the bullish and neutral scenarios — that the profit decline is strategic investment and that technicals are about to reverse — were pointed out during the debate as lacking support from report data. These unverified assumptions are precisely the 'faith-based investing' that the Research Manager initially sought to avoid; my review process successfully filtered them out. 3. **Clarity of downside risk was confirmed**: The safety analyst's interpretation of technical and fundamental deterioration (e.g., 'catching a falling knife,' 'dead cat bounce' risk) is not only flawless but resonates with the Research Manager's view that 'falling on rising volume, rallying on shrinking volume indicates bullish weakness,' together forming a complete bearish picture. Therefore, my ruling is not merely support for a viewpoint, but a confirmation of a comprehensive evidence-based risk management discipline. In the current Alibaba trade, selling is not conservatism; it is clarity.